ProfileGDS4718 / 230558_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 46% 44% 40% 50% 40% 45% 42% 44% 46% 43% 45% 40% 47% 43% 40% 41% 46% 41% 43% 45% 50% 43% 45% 41% 42% 43% 43% 43% 29% 47% 46% 38% 45% 44% 46% 44% 47% 48% 43% 38% 42% 45% 43% 39% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.2826446
GSM549102patient 115, normal, homogenized [OPG study]5.2252944
GSM549104patient 119, normal, homogenized [OPG study]4.978440
GSM549108patient 138, normal, homogenized [OPG study]5.5328750
GSM549119patient 077, normal, homogenized [OPG study]5.0176140
GSM549133patient 032, cancer, homogenized [OPG study]5.1999245
GSM549139patient 042, cancer, homogenized [OPG study]5.0747442
GSM549099patient 107, normal, homogenized [OPG study]5.200744
GSM549109patient 139, normal, homogenized [OPG study]5.3130146
GSM549110patient 046, normal, homogenized [OPG study]5.1645343
GSM549114patient 063, normal, homogenized [OPG study]5.2013745
GSM549122patient 082, normal, homogenized [OPG study]5.0200840
GSM549134patient 033, cancer, homogenized [OPG study]5.3183247
GSM549136patient 036, cancer, homogenized [OPG study]5.1006443
GSM549140patient 044, cancer, homogenized [OPG study]4.9427940
GSM549111patient 047, normal, homogenized [OPG study]5.0417741
GSM549113patient 057, normal, homogenized [OPG study]5.251746
GSM549132patient 031, cancer, homogenized [OPG study]5.0200841
GSM549137patient 038, cancer, homogenized [OPG study]5.1027943
GSM549142patient 047, cancer, homogenized [OPG study]5.3591545
GSM549100patient 110, normal, homogenized [OPG study]5.5289350
GSM549107patient 135, normal, homogenized [OPG study]5.1029343
GSM549115patient 068, normal, homogenized [OPG study]5.1912445
GSM549116patient 072, normal, homogenized [OPG study]5.0128641
GSM549120patient 078, normal, homogenized [OPG study]5.0685842
GSM549131patient 030, cancer, homogenized [OPG study]5.066143
GSM549118patient 074, normal, homogenized [OPG study]5.1486943
GSM549129patient 027, cancer, homogenized [OPG study]5.1555943
GSM549123patient 088, normal, homogenized [OPG study]4.4968829
GSM549124patient 006, cancer, homogenized [OPG study]5.379147
GSM549126patient 015, cancer, homogenized [OPG study]5.2766146
GSM549128patient 025, cancer, homogenized [OPG study]4.8620938
GSM549103patient 117, normal, homogenized [OPG study]5.3163145
GSM549117patient 073, normal, homogenized [OPG study]5.1612544
GSM549138patient 041, cancer, homogenized [OPG study]5.2722246
GSM549141patient 045, cancer, homogenized [OPG study]5.1406744
GSM549130patient 028, cancer, homogenized [OPG study]5.3456847
GSM549101patient 111, normal, homogenized [OPG study]5.443248
GSM549105patient 128, normal, homogenized [OPG study]5.1678443
GSM549106patient 134, normal, homogenized [OPG study]4.8330538
GSM549112patient 048, normal, homogenized [OPG study]5.0966142
GSM549125patient 011, cancer, homogenized [OPG study]5.2575645
GSM549127patient 024, cancer, homogenized [OPG study]5.1217443
GSM549135patient 035, cancer, homogenized [OPG study]4.8937839